![Jonathan Yingling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Yingling
Chief Tech/Sci/R&D Officer at
ARCUS BIOSCIENCES, INC.
Profile
Dr. Jonathan Yingling is a Chief Scientific Officer at Arcus Biosciences, Inc. Dr. Yingling was previously employed as a Chief Scientific Officer & Senior Vice President by Idera Pharmaceuticals, Inc., a Chief Scientific Officer by DNIB Unwind, Inc., a Vice President-Oncology Discovery by Bristol Myers Squibb Co., and a Vice President-Translational Science & Technology by Eli Lilly & Co. He received his undergraduate degree from The College of William & Mary and a doctorate degree from Duke University School of Medicine.
Jonathan Yingling active positions
| Companies | Position | Start |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2020-09-30 |
Former positions of Jonathan Yingling
| Companies | Position | End |
|---|---|---|
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Chief Tech/Sci/R&D Officer | 2020-01-30 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2015-09-30 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| DNIB UNWIND INC | Chief Tech/Sci/R&D Officer | - |
Training of Jonathan Yingling
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
- Stock Market
- Insiders
- Jonathan Yingling
